BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15215152)

  • 21. Mortality among tuberculosis patients in the Democratic Republic of Congo.
    Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
    Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of AIDS with disseminated Mycobacterium kansasii infection in which Mycobacterium, avium complex was also detected from his sputum repeatedly].
    Sasaki Y; Yamagishi F; Suzuki K; Saitoh M; Izumizaki M
    Kekkaku; 1997 Oct; 72(10):573-7. PubMed ID: 9386356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-tuberculous mycobacteria pulmonary infection: management and follow-up of 31 infected patients.
    Andréjak C; Lescure FX; Douadi Y; Laurans G; Smail A; Duhaut P; Jounieaux V; Schmit JL
    J Infect; 2007 Jul; 55(1):34-40. PubMed ID: 17360040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. False-positive Gen-Probe direct Mycobacterium tuberculosis amplification test results for patients with pulmonary M. kansasii and M. avium infections.
    Jorgensen JH; Salinas JR; Paxson R; Magnon K; Patterson JE; Patterson TF
    J Clin Microbiol; 1999 Jan; 37(1):175-8. PubMed ID: 9854086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association.
    Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 2):S1-25. PubMed ID: 9279284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
    Levine B; Chaisson RE
    Ann Intern Med; 1991 May; 114(10):861-8. PubMed ID: 1673053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-related nontuberculous mycobacterial infection: incidence, survival analysis and associated risk factors.
    Arastéh KN; Cordes C; Ewers M; Simon V; Dietz E; Futh UM; Brockmeyer NH; L'age MP
    Eur J Med Res; 2000 Oct; 5(10):424-30. PubMed ID: 11076783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in HIV infection.
    Marras TK; Daley CL
    J Acquir Immune Defic Syndr; 2004 Aug; 36(4):883-9. PubMed ID: 15220694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mycobacterium kansasii infection in patients with human immunodeficiency virus infection].
    Boudon P; Le Pennec MP; Malbec D; Mathieu M; Slama JL; Manet P; Pines E; Kretz S; Giacomini T
    Rev Med Interne; 1995; 16(10):747-51. PubMed ID: 8525154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study.
    Manfredi R; Nanetti A; Valentini R; Ferri M; Morelli S; Calza L
    HIV Med; 2004 Nov; 5(6):431-6. PubMed ID: 15544696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
    Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
    Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Kansas City AIDS Research Consortium.
    Bamberger DM; Driks MR; Gupta MR; O'Connor MC; Jost PM; Neihart RE; McKinsey DS; Moore LA
    Clin Infect Dis; 1994 Mar; 18(3):395-400. PubMed ID: 8011822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors for the survival of patients with AIDS cholangiopathy.
    Ko WF; Cello JP; Rogers SJ; Lecours A
    Am J Gastroenterol; 2003 Oct; 98(10):2176-81. PubMed ID: 14572564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients: validation of severity criteria. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.
    Cordero E; Pachón J; Rivero A; Girón JA; Gómez-Mateos J; Merino MD; Torres-Tortosa M; González-Serrano M; Aliaga L; Collado A; Hernández-Quero J; Barrera A; Nuño E
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2063-8. PubMed ID: 11112115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
    López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
    J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.